Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaaki Inoue

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Kyobu Geka. the Japanese Journal of Thoracic Surgery|December 24, 2010
[Treatment recommendations for adrenal metastasis of non-small cell lung cancer]Takashi Iwanami, Hidetaka Uramoto, Tetsuro Baba, et al.
Chemical Research in Toxicology|January 9, 2010
DNA modifications by the omega-3 lipid peroxidation-derived mutagen 4-oxo-2-hexenal in vitro and their analysis in mouse and human DNAKazuaki Kawai, Pei-Hsin Chou, Tomonari Matsuda, et al.
Cureus|June 25, 2025
Phase II Study of Platinum Re-administration in Non-small Cell Lung Cancer Following Chemoimmunotherapy ResistanceKiichiro Ninomiya, Shinobu Hosokawa, Toshihide Yokoyama, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|May 7, 2003
Pleomorphic carcinoma: report of a case with massive pleural effusion and asbestos particlesTsunehiro Oyama, Toshihiro Osaki, Toyohi Isse, et al.
Cancer Research Communications|January 13, 2026
Clinical characteristics and spatial transcriptome analysis of non-small cell lung cancers exhibiting early alectinib resistance: a retrospective OLCSG studyTadahiro Kuribayashi, Go Makimoto, Kadoaki Ohashi, et al.
Cancers|December 23, 2022
The Effect of Pleural Effusion on Prognosis in Patients with Non-Small Cell Lung Cancer Undergoing Immunochemotherapy: A Retrospective Observational StudyTomoka Nishimura, Eiki Ichihara, Toshihide Yokoyama, et al.
International Journal of Clinical Oncology|August 28, 2025
Impact of antibiotic use on survival in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor and chemotherapyNobuaki Ochi, Eiki Ichihara, Toshihide Yokoyama, et al.
Lung|January 24, 2024
Efficacy and Safety of Re-administration of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) After EGFR-TKI-Induced Interstitial Lung Disease (CS-Lung-005)Nobuhiro Kanaji, Eiki Ichihara, Takaaki Tanaka, et al.
Journal of Cancer Research and Clinical Oncology|October 29, 2022
More than one-third of advanced non-small-cell lung cancer patients do not receive immunochemotherapy due to intoleranceChihiro Ando, Eiki Ichihara, Toshihide Yokoyama, et al.
Cancers|December 17, 2024
Frequency and Significance of Body Weight Loss During Immunochemotherapy in Patients with Advanced Non-Small Cell Lung CancerMasataka Taoka, Eiki Ichihara, Toshihide Yokoyama, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Kyobu Geka. the Japanese Journal of Thoracic Surgery|December 24, 2010
[Treatment recommendations for adrenal metastasis of non-small cell lung cancer]Takashi Iwanami, Hidetaka Uramoto, Tetsuro Baba, et al.
Chemical Research in Toxicology|January 9, 2010
DNA modifications by the omega-3 lipid peroxidation-derived mutagen 4-oxo-2-hexenal in vitro and their analysis in mouse and human DNAKazuaki Kawai, Pei-Hsin Chou, Tomonari Matsuda, et al.
Cureus|June 25, 2025
Phase II Study of Platinum Re-administration in Non-small Cell Lung Cancer Following Chemoimmunotherapy ResistanceKiichiro Ninomiya, Shinobu Hosokawa, Toshihide Yokoyama, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|May 7, 2003
Pleomorphic carcinoma: report of a case with massive pleural effusion and asbestos particlesTsunehiro Oyama, Toshihiro Osaki, Toyohi Isse, et al.
Cancer Research Communications|January 13, 2026
Clinical characteristics and spatial transcriptome analysis of non-small cell lung cancers exhibiting early alectinib resistance: a retrospective OLCSG studyTadahiro Kuribayashi, Go Makimoto, Kadoaki Ohashi, et al.
Cancers|December 23, 2022
The Effect of Pleural Effusion on Prognosis in Patients with Non-Small Cell Lung Cancer Undergoing Immunochemotherapy: A Retrospective Observational StudyTomoka Nishimura, Eiki Ichihara, Toshihide Yokoyama, et al.
International Journal of Clinical Oncology|August 28, 2025
Impact of antibiotic use on survival in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor and chemotherapyNobuaki Ochi, Eiki Ichihara, Toshihide Yokoyama, et al.
Lung|January 24, 2024
Efficacy and Safety of Re-administration of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) After EGFR-TKI-Induced Interstitial Lung Disease (CS-Lung-005)Nobuhiro Kanaji, Eiki Ichihara, Takaaki Tanaka, et al.
Journal of Cancer Research and Clinical Oncology|October 29, 2022
More than one-third of advanced non-small-cell lung cancer patients do not receive immunochemotherapy due to intoleranceChihiro Ando, Eiki Ichihara, Toshihide Yokoyama, et al.
Cancers|December 17, 2024
Frequency and Significance of Body Weight Loss During Immunochemotherapy in Patients with Advanced Non-Small Cell Lung CancerMasataka Taoka, Eiki Ichihara, Toshihide Yokoyama, et al.
Pageof 6